A Utah company that plans to develop biomarker tests to diagnose genetic disease was formally launched Wednesday, with the announcement that it has closed a $5.8 million funding round.
LineaGen http://www.lineagen.com is a company spun off research at the University of Utah, which has discovered more genes related to diseases than any other university. Besides developing diagnostic tools using biomarkers, the company plans to license intellectual property to companies to help develop treatments.
By Lois M. Collins Deseret Morning News
Full Story: http://www.deseretnews.com/article/1,5143,695237470,00.html